Correlations Between Soluble Receptor for Advanced Glycation End Products and Heme Oxygenase-1 in Post-COVID-19 Patients With Telogen Effluvium

    May 2026 in “ Journal of the Egyptian Womenʼs Dermatologic Society ”
    Ihab Y. Abdallah, Mona M.A. Aboelkhier, Lina A. Mohammed, Nader N. Nazmy
    Studysummary This study found that post-COVID-19 telogen effluvium is strongly associated with elevated oxidative stress marker sRAGE and reduced antioxidant marker HO-1, suggesting potential biomarkers for early diagnosis and monitoring.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →

    Research cited in this study 9

    1. Reporting Cases of Telogen Effluvium as a Sequelae of COVID-19 Infection Journal of Drug Delivery and Therapeutics · 2022
    2. A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation Journal of Medical Virology · 2021
    3. Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management JAAD International · 2021
    4. Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium Journal of The American Academy of Dermatology · 2021
    5. Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients Experimental Dermatology · 2021
    6. Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2 Revista da Sociedade Portuguesa de Dermatologia e Venereologia · 2021
    7. The Role of Sleep in Telogen Effluvium and Trichodynia: A Commentary in the Context of the Current Pandemic Journal of Cosmetic Dermatology · 2021
    8. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    9. Post-Discharge Persistent Symptoms and Health-Related Quality of Life After Hospitalization for COVID-19 Journal of Infection · 2020